Excited for this session at HRS. We will be sharing our work using PaceMate data to do a deep dive on ICD battery longevity- including improvements over the last decade, vendor variations, the impact of adding leads.

Last days for abstract submissions - don't miss the chance to present in Sydney #APHRS2024

Great meeting with the leadership and medical advisory board from PaceMate. An amazing group doing important work. Some really exciting science at #HRS2024 including our work on ICD battery longevity that we are presenting on Saturday. Prash Sanders Tina Baykaner

Excited about our work quantifying battery longevity in ICDs over time, by type and by vendor. Important insights, including that adding an atrial lead costs 2-3 years of battery longevity. Plus, nothing is cooler than presenting while wearing an 80’s style Walkman AV device.

Our data on the use of Amulet after failed Watchman. Vital contribution to the field so that we know the options after a failed first LAAO procedure

Remarkable program in Adelaide committed to the pursuit of progress and truth through science. Congratulations Prash Sanders and crew

Our work on ICD battery longevity using #PaceMate data. Substantial differences by vendor but gap has narrowed with more recent implants. Also important to note the loss of 2-3 years of longevity with each additional lead so need to consider the need for atrial lead carefully.

Full paper coming soon. Important and under-appreciated story in ICD space. Thanks to #PaceMate for the remarkable data and my partner with this work Benjamin Steinberg

The potential for PFA to work through scar and on difficult to ablate structures in the ventricles does seem very exciting.

#EPeeps... what is your general experience with #QDot? This research letter is certainly concerning. Open chest complications. Very high volume operators. Biosense Webster, Amin Al-Ahmad, MD, would love to hear your thoughts too.

Variation across manufacturers although substantial room for improvement with all ILRs. Data from #PaceMate once again showing the clinical and scientific potential of aggregating CIED remote monitoring data into a single powerful platform. Prash Sanders Tina Baykaner

Super important work from our colleagues Cleveland Clinic evaluating PFA vs RFA for challenging VTs in a swine model. Just beginning to explore the possibilities with this new energy source for challenging locations in the atria (mitral line, LAA) and the ventricles.

Our own Rachel Lampert Yale Cardiology talking about the 2024 HRS Expert Consensus Statement on Arrhythmias in the Athlete. A remarkable resource for EP and cardiology. Pragmatic and detailed guidance regarding if, when and how to get patients back to play safely.

Really informative review on AI in CV care. Rohan Khera Yale Cardiology leading the way in this space. Brilliant start to the Harlan Krumholz era JACC Journals!

Congratulations Euan! Inspired choice by the institution.

Adding ASA to DOAC on discharge after LAAO markedly increases risk of major bleeding w/o decreasing stroke/TIA or DRT. But ~50% of patients are still discharged on DOAC+ASA! This data strongly supports DOAC alone. Jonathan Piccini, MD, MHS Jonathan Hsu, MD Samir Kapadia nam12.safelinks.protection.outlook.com/?url=https%3A%…

Really big news in the remote monitoring space.

Nice article by Todd Neale TCTMD on our study showing that DOAC alone after LAAO was associated with lower risk of major adverse events, and particularly bleeding compared with DOAC + aspirin. tctmd.com/news/dropping-…

Fantastic work Pasquale Santangeli. We have all been waiting with bated breath to see if PFA will allow us to better ablate VT substrate, particularly with pre-existing scar.

A true Yale giant. Thanks for everything John